Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Geoffrey D Barnes

Showing results (131-140 of 290) with videos related to

Pageof 29
Sort By:
JAMA Cardiology|January 5, 2017
Discontinuation of Warfarin Therapy for Patients With Atrial Fibrillation: The Michigan Anticoagulation Quality Improvement Initiative ExperienceGeoffrey D Barnes, Scott Kaatz, Alexis Lopez, et al.
Joint Commission Journal on Quality and Patient Safety|February 2, 2020
"Reduce the Likelihood of Patient Harm Associated with the Use of Anticoagulant Therapy": Commentary from the Anticoagulation Forum on the Updated Joint Commission NPSG.03.05.01 Elements of PerformanceWilliam E Dager, Jack Ansell, Geoffrey D Barnes, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 17, 2024
Prescribing of Proton Pump Inhibitors for Prevention of Upper Gastrointestinal Bleeding in US Outpatient VisitsJacob E Kurlander, John N Mafi, Michael J Racz, et al.
JMIR Medical Informatics|January 26, 2025
Performance of an Electronic Health Record-Based Automated Pulmonary Embolism Severity Index Score Calculator: Cohort Study in the Emergency DepartmentElizabeth Joyce, James McMullen, Xiaowen Kong, et al.
Chest|December 13, 2016
Diversity in the Pulmonary Embolism Response Team Model: An Organizational Survey of the National PERT Consortium MembersGeoffrey D Barnes, Christopher Kabrhel, D Mark Courtney, et al.
Vascular Medicine (London, England)|August 23, 2024
Comparing DOAC and warfarin outcomes in an obese population using the 'real-world' Michigan Anticoagulation Quality Improvement Initiative (MAQI<sup>2</sup>) registryNelish Ardeshna, Thane Feldeisen, Xiaowen Kong, et al.
American Heart Journal|August 27, 2021
Cardiovascular and major bleeding outcomes with antiplatelet and direct oral anticoagulants in patients with acute coronary syndrome and atrial fibrillation: A population-based analysisGhadeer K Dawwas, Geoffrey D Barnes, Eric Dietrich, et al.
Vascular Medicine (London, England)|May 23, 2018
The impact of a multi-specialty team for high risk pulmonary embolism on resident and fellow educationAyman Elbadawi, Colin Wright, Dhwani Patel, et al.
Frontiers in Pharmacology|December 12, 2022
Eight pharmacokinetic genetic variants are not associated with the risk of bleeding from direct oral anticoagulants in non-valvular atrial fibrillation patientsAlessandra M Campos-Staffico, Michael P Dorsch, Geoffrey D Barnes, et al.
JAMA Network Open|January 3, 2025
Factors in Initial Anticoagulation Choice in Hospitalized Patients With Pulmonary EmbolismWilliam B Stubblefield, Ron Helderman, Natalie Strokes, et al.
Pageof 29

Showing results (131-140 of 290) with videos related to

Sort By:
Pageof 29
JAMA Cardiology|January 5, 2017
Discontinuation of Warfarin Therapy for Patients With Atrial Fibrillation: The Michigan Anticoagulation Quality Improvement Initiative ExperienceGeoffrey D Barnes, Scott Kaatz, Alexis Lopez, et al.
Joint Commission Journal on Quality and Patient Safety|February 2, 2020
"Reduce the Likelihood of Patient Harm Associated with the Use of Anticoagulant Therapy": Commentary from the Anticoagulation Forum on the Updated Joint Commission NPSG.03.05.01 Elements of PerformanceWilliam E Dager, Jack Ansell, Geoffrey D Barnes, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 17, 2024
Prescribing of Proton Pump Inhibitors for Prevention of Upper Gastrointestinal Bleeding in US Outpatient VisitsJacob E Kurlander, John N Mafi, Michael J Racz, et al.
JMIR Medical Informatics|January 26, 2025
Performance of an Electronic Health Record-Based Automated Pulmonary Embolism Severity Index Score Calculator: Cohort Study in the Emergency DepartmentElizabeth Joyce, James McMullen, Xiaowen Kong, et al.
Chest|December 13, 2016
Diversity in the Pulmonary Embolism Response Team Model: An Organizational Survey of the National PERT Consortium MembersGeoffrey D Barnes, Christopher Kabrhel, D Mark Courtney, et al.
Vascular Medicine (London, England)|August 23, 2024
Comparing DOAC and warfarin outcomes in an obese population using the 'real-world' Michigan Anticoagulation Quality Improvement Initiative (MAQI<sup>2</sup>) registryNelish Ardeshna, Thane Feldeisen, Xiaowen Kong, et al.
American Heart Journal|August 27, 2021
Cardiovascular and major bleeding outcomes with antiplatelet and direct oral anticoagulants in patients with acute coronary syndrome and atrial fibrillation: A population-based analysisGhadeer K Dawwas, Geoffrey D Barnes, Eric Dietrich, et al.
Vascular Medicine (London, England)|May 23, 2018
The impact of a multi-specialty team for high risk pulmonary embolism on resident and fellow educationAyman Elbadawi, Colin Wright, Dhwani Patel, et al.
Frontiers in Pharmacology|December 12, 2022
Eight pharmacokinetic genetic variants are not associated with the risk of bleeding from direct oral anticoagulants in non-valvular atrial fibrillation patientsAlessandra M Campos-Staffico, Michael P Dorsch, Geoffrey D Barnes, et al.
JAMA Network Open|January 3, 2025
Factors in Initial Anticoagulation Choice in Hospitalized Patients With Pulmonary EmbolismWilliam B Stubblefield, Ron Helderman, Natalie Strokes, et al.
Pageof 29